Allergi-Asthma Center Of San Jose Inc San Jose, CA - 95119

Allergi-Asthma Center Of San Jose Inc is categorized under Doctors in San Jose, CA and active since 1994.

Allergi-Asthma Center Of San Jose Inc was established in 1994, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Doctors business, which does work in the B2C market, and is classified as a Doctors, under code number 621111 by the NAICS.

If you are seeking more information, feel free to contact Dr James Andrews at the company’s single location by writing to 275 Hospital Parkway # 600, San Jose, California CA 95119 or by phoning (408) 629-6188. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Allergi-Asthma Center Of San Jose Inc
Contact Person: Dr James Andrews
Address: 275 Hospital Parkway # 600, San Jose, California 95119
Phone Number: (408) 629-6188
Annual Revenue (USD): $100.000 to $499.999
Founded: 1994
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Doctors
SIC Code: 8011
NAICS Code: 621111
Share This Business:

Allergi-Asthma Center Of San Jose Inc was started in 1994 to provide professional Doctors under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.

Feel free to contact Dr James Andrews for inquiries that concern Allergi-Asthma Center Of San Jose Inc by calling the company number (408) 629-6188, as your correspondence is most welcome. Additionally, the physical location of the single location of Allergi-Asthma Center Of San Jose Inc can be found at the coordinates 37.239591,-121.801833 as well as the street address 275 Hospital Parkway # 600 in San Jose, California 95119.

For its online presence, you may visit Allergi-Asthma Center Of San Jose Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.